A clinical stage biopharmaceutical company developing best-in-class novel therapeutics to relieve the suffering of patients with neurodegenerative diseases, psychiatric disorders and pain.
Total raised: $17.5M
Investors 2
| Date | Name | Website |
| - | KTB Networ... | ktbnetwork... |
| - | WI Harper ... | wiharper.c... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 20.09.2017 | Series B | $17.5M | - | finsmes.co... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 17.09.2020 | XWPharma A... | - | - | - | jnjinnovat... |
| 20.09.2017 | China’s Wu... | Chinese neurological disorders... | Biotech | - | fiercebiot... |
| 20.09.2017 | XW Labs Se... | XW Laboratories Inc., a Wuhan,... | China | - | finsmes.co... |